Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Neurology

Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson’s disease

Christiaan Schiepers, Daniel Silverman, Magnus Dahlbom, Johannes Czernin, Michael Phelps and Sung-Cheng Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1274;
Christiaan Schiepers
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Silverman
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magnus Dahlbom
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Czernin
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Phelps
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sung-Cheng Huang
1David Geffen School of Medicine at UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1274

Objectives FDOPA kinetics are used for diagnosing Parkinson’s disease (PD). The dynamic PET limits clinical applicability. For standardization of tracer administration, a pump was used at a fixed rate, 5 mL/min for 3 min. PET-CT images were analyzed with Patlak analysis and by calculating uptake-ratios. A database was defined for patients without motor disturbances, and compared to patients without PD.

Methods 10 patients with treated brain tumor, stable (Negative Controls, negC) and 20 patients with tremors, age 31-76, were preloaded with 200 mg Carbidopa, and received 5-10 mCi 18F-DOPA 1 hr later. CT was for attenuation correction. PET acquisition was 90 min (from injection) for negC and 30 min (starting at 1 hr) for others. As input function (IF) a cerebellar or occipital cortex curve was used. A ‘standard IF’ was obtained by averaging TACs of negC normalized to the area-under-the-curve. Individual IF was derived by scaling standard IF to cerebellar or occipital uptake. VOIs of the striata were defined manually or by thresholding. Patlak analysis was done over 30 min starting at 1 hr. No corrections were applied for partial volume or metabolites. Uptake ratios relative to the cerebellar and occipital cortex were calculated.

Results Normal influx rate (Ki) with PET-CT was different (p<0.05) from historical data with PET-only. Of 20 tremor patients 10 were diagnosed with PD, 3 MSA, and 7 negative (noPD). The noPD patients are similar to negC. Striatal-to-Occipital Ratio (SOR) is as efficient as Ki for PD. The ‘standard IF’ shortens data acquisition by 1 hr and yields similar Ki. Correlation coefficients are higher with an Occipital IF than Cerebellar IF: 0.96 vs 0.88 for the caudate, and 0.96 vs 0.91 for the putamen. The anterior-posterior gradient of the putamen was most sensitive to diagnose PD.

Conclusions A database of Ki & SOR was established for FDOPA metabolism with PET-CT, using tracer delivery via pump, ‘standard IF’ scaled by actual uptake, and Patlak plot or SOR. This procedure permits differentiation of clinical Parkinsonism

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson’s disease
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson’s disease
Christiaan Schiepers, Daniel Silverman, Magnus Dahlbom, Johannes Czernin, Michael Phelps, Sung-Cheng Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1274;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Striatal 18F-DOPA metabolism with PET-CT in patients with and without Parkinson’s disease
Christiaan Schiepers, Daniel Silverman, Magnus Dahlbom, Johannes Czernin, Michael Phelps, Sung-Cheng Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1274;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Neurology

  • Influence of PET scan duration on diagnostic accuracy of β-amyloid (Aβ) imaging with florbetaben in Alzheimer disease (AD)
  • Regional difference in cerebrovascular reactivity by acetazolamide in normal volunteers: A PET study with H215O
  • Improved F-18 florbetapir (AV-45) PET imaging reading by brain cortex guide using dual time point scanning protocol
Show more Neurosciences: Neurology

Neurology Posters

  • IDH1 mutation is associated with low FDG upatke in cerebral gliomas associated with low FDG uptake in cerebral gliomas.
  • Targeted therapy and immunotherapy response assessment with F-18 FLT PET in melanoma brain metastasis (MBM)
  • Correlation of 4’-[methyl-11C]thiothymidine uptake on PET/CT with proliferation and survival in patients with newly diagnosed gliomas.
Show more Neurology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire